Skip to main content
OpenTrials
Completed

NCT Number: NCT02472015

Dementia in Long Term Care Facilities: Telemedicine for the Management of Neuropsychiatric Symptoms

Telemedicine may facilitate adequate treatment of Neuropsychiatric symptoms (NPS) by identifying underlying causes and tailoring a treatment plan (pharmacological or non-pharmacologic treatments including provision of staff education and support, training in problem solving, and targeted therapy directed at the underlying causes for specific behaviors).

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UHLimoges, Limoges, France

Loading trial locations.

About this study

During a 6-months period, patients will be included in both arms, whenever they present a disruptive NPS that requires a specialist consultation based on the long-term care facility (LTCF) staff judgment. In the intervention group, a telemedicine (TM) consultation between the LTCF staff (medical and nurse staff) and the Memory Center from the University Hospital, will occur at inclusion (T0). Then, a second TM consultation will occur at 1 month (T1). In the control group management of NPS will be done as usual care. In both groups, patients' parameters such as non-programmed hospitalizations and/or consultations due to disruptive NPS, psychotropic drugs use, and health costs, will be evaluated at inclusion, 1 month and at 2 months. Acceptability of the TM among the LTCF staff will be assessed during the study in the intervention group.

The two university hospitals are composed of a group of institutions for elderly people located near Toulouse and Limoges.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient aged 65 or more, with a dementia diagnosed by a specialist or the general practitioner;
  • patient presenting with a disruptive NPS as defined in French Haute Autorité de Santé (HAS) recommendations (2009), that requires a specialist consultation based on the LTCF staff judgment;
  • informed and written consent by the patient or the legal representative or the reliable person when appropriate;
  • general practitioner agreement.

Exclusion criteria

  • patient's life expectancy less than 6 months;
  • Non agreement of study participation of patients or legal representative or the reliable person when appropriate.

Treatment and study plan

Telemedicine

Procedure

psycho-behavioural care by telemedicine

Primary outcomes

  1. Acceptability of the TM among the LTCF staff

    Time frame: 6 months

    Acceptability of the telemedicine (TM) among the LTCF staff which will be assessed in the intervention group by quantitative indicators (proportion of the solicitation of the TM solution among patients with disruptive NPS, the delay to obtain a TM consultation and the number of the staff participants at each TM consultation) and qualitative indicators (staff global satisfaction will be evaluated by focus groups and interviewing).

Secondary outcomes

  1. Rate of non-programmed hospitalizations and/or consultation due to disruptive NPS

    Time frame: 6 months

    Calculation of the rate of non-programmed hospitalizations and/or consultation due to disruptive NPS in both groups

  2. The psychotropic drugs used

    Time frame: 6 months

    Description of psychotropic drugs used in both groups

  3. describe the health costs

    Time frame: 6 months

    Description of the health costs in both groups

  4. describe the estimation of the cluster effect ("design effect")

    Time frame: 6 months

    Estimation of the cluster effect ("design effect") in both groups

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Registry information

Official study title

Dementia in Long Term Care Facilities: Telemedicine for the Management of Neuropsychiatric Symptoms.

Acronym: DETECT

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Jun 15, 2015
Registry last updated
Jun 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.